Company Filing History:
1 out of 52,752 
1 out of 2,916 
Years Active: 1986-1987
Title: The Innovations of Mitchio Mitomi
Introduction
Mitchio Mitomi is a notable inventor based in Otawara, Japan. He has made significant contributions to the field of nuclear magnetic resonance (NMR) technology. With a total of 2 patents, his work has advanced the capabilities of diagnostic apparatuses in medical and scientific applications.
Latest Patents
Mitchio Mitomi's latest patents include a field gradient correction apparatus for compensating static fields. This innovative device utilizes selective excitation to resonate nuclear spins within a predetermined planar slice of a target. The received NMR signals are then employed to correct the non-homogeneity of a static magnetic field based on the calculated spin-spin relaxation time T.sub.2 * of the observed NMR signal. Another significant patent is the nuclear magnetic resonance diagnostic apparatus, which is designed to reduce or eliminate low-frequency cyclic noise. This apparatus phase demodulates NMR signals using reference signals that match the frequency of the excitation signals. By changing the phases of the output reference signals by 180 degrees, the apparatus effectively demodulates the received NMR signals, which are divided into two signals of the same phase. The demodulated signals, being 180 degrees apart, are then added together to eliminate the cyclic noise component.
Career Highlights
Throughout his career, Mitchio Mitomi has worked with prominent companies such as Kabushiki Kaisha Toshiba and Tokyo Shibaura Denki Kabushiki Kaisha. His experience in these organizations has contributed to his expertise in the field of NMR technology.
Collaborations
Mitchio Mitomi has collaborated with notable individuals in his field, including Fumitoshi Kojima and Satoshi Sugiura. These collaborations have further enriched his work and innovations.
Conclusion
Mitchio Mitomi's contributions to the field of nuclear magnetic resonance technology are significant and impactful. His patents reflect a commitment to advancing diagnostic capabilities, and his collaborations highlight the importance of teamwork in innovation.